Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 4, 2001, Pages 452-459

  Ishikawa, Toru ^a   Ichida, Takafumi ^a   Sugitani, Soichi ^a   Tsuboi, Yasunori ^a   Genda, Takuya ^a   Sugahara, Satoshi ^a   Uehara, Kazuhiro ^a   Inayoshi, Jun ^a   Yokoyama, Junji ^a   Ishimoto, Yuiko ^a   Asakura, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Cox's regression hazard model; Enteric coated tegafur uracil; Hepatocellular carcinoma

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; TEGAFUR; UFT; URACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG INDUCED DISEASE; ENTERIC COATED TABLET; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; STATISTICAL MODEL; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0035041151     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02352.x     Document Type: Article

References (18)

1. Hepatocellular carcinoma: Recent progress
2. Multimodality treatment of hepatocellular carcinoma
3. The medical management of hepatocellular carcinoma in Japan: A review with implications for HCC seen in the west
4. Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: A randomized, controlled trial
5. Phase II of flutamide in the treatment of hepatocellular carcinoma
6. Treatment of hepatocellular carcinoma with octreotide: A randomized control study
7. Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil
8. The general rules for the clinical and pathological study of primary liver cancer
9. The analysis of repeated measures: A practical review with examples
10. Nonparametric estimation from incomplete observations
11. Regression models and life tables
12. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients
13. Treatment of hepatocellular carcinoma
14. Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: Implication in 5-fluorouracil-based chemotherapy
15. Survival without tumor shrinkage: Re-evaluation of survival gain by cytostatic effect of chemotherapy
16. The natural history of hepatocellular carcinoma